CN117205294A - 一种治疗肺炎病毒的中药组合物 - Google Patents
一种治疗肺炎病毒的中药组合物 Download PDFInfo
- Publication number
- CN117205294A CN117205294A CN202311342604.XA CN202311342604A CN117205294A CN 117205294 A CN117205294 A CN 117205294A CN 202311342604 A CN202311342604 A CN 202311342604A CN 117205294 A CN117205294 A CN 117205294A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- chinese medicine
- traditional chinese
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 42
- 239000000203 mixture Substances 0.000 title claims abstract description 23
- 241000711902 Pneumovirus Species 0.000 title claims abstract description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 14
- 244000131316 Panax pseudoginseng Species 0.000 claims description 25
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims description 12
- 244000061520 Angelica archangelica Species 0.000 claims description 11
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 11
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 11
- 241000282994 Cervidae Species 0.000 claims description 11
- 244000248416 Fagopyrum cymosum Species 0.000 claims description 11
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 11
- 244000082204 Phyllostachys viridis Species 0.000 claims description 11
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 11
- 244000273928 Zingiber officinale Species 0.000 claims description 11
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 11
- 239000011425 bamboo Substances 0.000 claims description 11
- 235000008397 ginger Nutrition 0.000 claims description 11
- 241000213006 Angelica dahurica Species 0.000 claims description 10
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 10
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 10
- 240000000691 Houttuynia cordata Species 0.000 claims description 10
- 244000236658 Paeonia lactiflora Species 0.000 claims description 10
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims description 10
- 244000274050 Platycodon grandiflorum Species 0.000 claims description 10
- 241000132012 Atractylodes Species 0.000 claims description 9
- 241000361919 Metaphire sieboldi Species 0.000 claims description 9
- 241000594310 Randia aculeata Species 0.000 claims description 9
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 9
- 235000011477 liquorice Nutrition 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 235000008326 Trichosanthes anguina Nutrition 0.000 claims description 8
- 244000078912 Trichosanthes cucumerina Species 0.000 claims description 8
- 235000013399 edible fruits Nutrition 0.000 claims description 8
- 241001522129 Pinellia Species 0.000 claims description 7
- 229940107666 astragalus root Drugs 0.000 claims description 7
- 235000013717 Houttuynia Nutrition 0.000 claims description 6
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims description 6
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 5
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 5
- 235000013719 Houttuynia cordata Nutrition 0.000 claims description 4
- 235000006751 Platycodon Nutrition 0.000 claims description 4
- 241001671204 Stemona Species 0.000 claims description 4
- 241000877344 Strophanthus divaricatus Species 0.000 claims description 4
- 244000185386 Thladiantha grosvenorii Species 0.000 claims description 4
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 claims description 4
- 229930189914 platycodon Natural products 0.000 claims description 4
- 244000081426 Ranunculus ficaria Species 0.000 claims description 3
- 235000002226 Ranunculus ficaria Nutrition 0.000 claims description 3
- 241001061264 Astragalus Species 0.000 claims description 2
- 235000006533 astragalus Nutrition 0.000 claims description 2
- 241001233061 earthworms Species 0.000 claims description 2
- 210000004233 talus Anatomy 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 47
- 229940079593 drug Drugs 0.000 abstract description 6
- 208000015181 infectious disease Diseases 0.000 abstract description 5
- 206010035737 Pneumonia viral Diseases 0.000 abstract description 4
- 208000009421 viral pneumonia Diseases 0.000 abstract description 4
- 239000009636 Huang Qi Substances 0.000 abstract description 3
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 abstract description 3
- 241000180649 Panax notoginseng Species 0.000 abstract description 2
- 235000003143 Panax notoginseng Nutrition 0.000 abstract description 2
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 abstract description 2
- 241000208340 Araliaceae Species 0.000 abstract 1
- 241000243684 Lumbricus Species 0.000 abstract 1
- 241000244155 Taenia Species 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 24
- 239000008280 blood Substances 0.000 description 24
- 206010011224 Cough Diseases 0.000 description 22
- 206010062717 Increased upper airway secretion Diseases 0.000 description 22
- 208000026435 phlegm Diseases 0.000 description 22
- 210000004072 lung Anatomy 0.000 description 15
- 208000002193 Pain Diseases 0.000 description 13
- 230000036407 pain Effects 0.000 description 13
- 230000001737 promoting effect Effects 0.000 description 8
- 206010047700 Vomiting Diseases 0.000 description 7
- 230000036039 immunity Effects 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 230000002633 protecting effect Effects 0.000 description 7
- 208000006673 asthma Diseases 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 239000003053 toxin Substances 0.000 description 6
- 231100000765 toxin Toxicity 0.000 description 6
- 230000008673 vomiting Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 206010035664 Pneumonia Diseases 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 201000007100 Pharyngitis Diseases 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 230000006793 arrhythmia Effects 0.000 description 4
- 206010003119 arrhythmia Diseases 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010008479 Chest Pain Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 239000002221 antipyretic Substances 0.000 description 3
- 210000003056 antler Anatomy 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 201000006474 Brain Ischemia Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010008120 Cerebral ischaemia Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 230000000954 anitussive effect Effects 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000003474 anti-emetic effect Effects 0.000 description 2
- 229940124584 antitussives Drugs 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000004223 radioprotective effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 201000001178 Bacterial Pneumonia Diseases 0.000 description 1
- 208000009079 Bronchial Spasm Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010022004 Influenza like illness Diseases 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000517306 Pediculus humanus corporis Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010053262 Skin swelling Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000009729 Ventricular Premature Complexes Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 208000016150 acute pharyngitis Diseases 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003160 antidiuretic agent Substances 0.000 description 1
- 229940124538 antidiuretic agent Drugs 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000002389 essential drug Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 150000002205 flavan-3-ol derivatives Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000037891 myocardial injury Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 150000004767 nitrides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- -1 radix Paeoniae alba Chemical compound 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗肺炎病毒的中药组合物,包含:鹿角片、山羊角、炙黄芪、人参、三七、北沙参、当归、白芷、黄芩、羌活、金荞麦、鱼腥草、清半夏、桔梗、全瓜蒌、玄参、杭芍、生白术、百部、地龙、露蜂房、前胡、白前、炙甘草、生姜、罗汉果、竹茹、土茯苓。本发明遵循中医处方用药原则,组方合理、用药安全、疗效好、使用方便,对治疗病毒性肺炎且感染危重型高危人疗效明显,成人儿童均可服用,值得临床推广。
Description
技术领域
本发明涉及中药技术领域,具体是指一种治疗肺炎病毒的中药组合物。
背景技术
肺炎是指肺组织的炎症或肿胀,肺泡中充满了脓液或其他液体,阻碍肺中的氧到达血液。肺炎传染性较强,人群普遍易感,且无特效治疗药物。2岁及一下的儿童、65岁及以上的老年人患病风险最高。最常见的病因是肺炎链球菌感染,此外也可由病毒、支原体、衣原体、真菌等病原体引起。
肺炎的症状从轻微到严重不等,这取决于引起感染的细菌或病毒类型、患者年龄和整体健康状况等因素。通常表现为发烧、寒战、疲劳、胸痛、咳痰、恶心呕吐或其他类似流感的症状。
治疗细菌性肺炎的常用方法是使用抗生素,并用退烧药、止痛药辅助治疗。病毒性肺炎通常以对症治疗为主。
目前,针对病毒性肺炎的治疗并没有特效药,尤其针对年龄在60岁以上的老年人、有心脑血管疾病等基础疾病者、免疫功能缺陷者等归类于重型/危重型高危人群的治疗,缺少效果显著的药物。
申请人基于中医和临床药理研究,提供了一种在临床恢复期进行治疗的治疗肺炎病毒的中药组合物。
发明内容
本发明要解决的技术问题是克服上述技术的缺陷,提供一种治疗肺炎病毒的中药组合物。
本发明包含以下重量份的中药原料:鹿角片13-75克、山羊角10-60克、炙黄芪10-60克、人参5-30克、三七5-30克、北沙参10-60克、当归5-30克、白芷8-50克、黄芩4-24克、羌活5-30克、金荞麦5-30克、鱼腥草10-60克、清半夏10-60克、桔梗5-30克、全瓜蒌8-48克、玄参10-60克、杭芍10-60克、生白术10-60克、百部5-30克、地龙8-48克、露蜂房2.5-15克、前胡5-30克、白前5-30克、炙甘草3-18克、生姜10-60克、罗汉果5-30克、竹茹5-30克、土茯苓4-24克。
优选的,所述中药组合物是由以下重量份的中药原料制成:鹿角片13-36克、山羊角10-30克、炙黄芪10-30克、人参5-15克、三七5-15克、北沙参10-30克、当归5-15克、白芷8-25克、黄芩4-11克、羌活5-15克、金荞麦5-15克、鱼腥草10-30克、清半夏10-30克、桔梗5-15克、全瓜蒌8-24克、玄参10-30克、杭芍10-30克、生白术10-30克、百部5-15克、地龙8-24克、露蜂房2.5-7.5克、前胡5-15克、白前5-15克、炙甘草3-9克、生姜10-30克、罗汉果5-15克、竹茹5-15克、土茯苓4-11克。
优选的,所述中药组合物是由以下重量份的中药原料制成:鹿角片13克、山羊角10克、炙黄芪10克、人参5克、三七5克、北沙参10克、当归5克、白芷8克、黄芩4克、羌活5克、金荞麦5克、鱼腥草10克、清半夏10克、桔梗5克、全瓜蒌8克、玄参10克、杭芍10克、生白术10克、百部5克、地龙8克、露蜂房2.5克、前胡5克、白前5克、炙甘草3克、生姜10克、罗汉果5克、竹茹5克、土茯苓4克。
优选的,鹿角片36克、山羊角30克、炙黄芪30克、人参15克、三七15克、北沙参30克、当归15克、白芷25克、黄芩11克、羌活15克、金荞麦15克、鱼腥草30克、清半夏30克、桔梗15克、全瓜蒌24克、玄参30克、杭芍30克、生白术30克、百部15克、地龙24克、露蜂房7.5克、前胡15克、白前15克、炙甘草9克、生姜30克、罗汉果15克、竹茹15克、土茯苓11克。
本发明中,鹿角片具有补肾壮阳、益血生精、强筋骨的功效;可以防癌抗癌,强筋健骨,温阳补肾,行血消肿,滋补身体,促进儿童生长发育的功效;鹿角中含有25种氨基酸、胶质、磷酸钙、碳酸钙、磷酸镁及氮化物等,对人体有很好的滋补作用,鹿角可以促进钙的吸收和体内的潴留,使血中钙略有增高,帮助对抗骨质疏松,延缓衰老;
山羊角可以平肝熄风、清肝明目、凉血解毒、清热解痉,有散瘀止痛,活血止血的功效;有解热,镇静,降压,抗病毒,增强免疫系统功能的作用;
炙黄芪具有益气补中生血的功效;用于脾虚、肺虚,气虚乏力、食少便溏;肺气虚导致的咳嗽、气短、气血弱;
人参具有大补元气,复脉固脱,补脾益肺,生津养血,安神益智的功效;能抗休克、强心、降血压、抗缺氧和保护心肌、改善血液流变学和抗血栓形成;能兴奋垂体-肾上腺皮质系统、抗应激、提高免疫功能、增强造血功能、调节中枢神经系统兴奋与抑制过程的平衡、促进学习记忆、抗疲劳;能促进蛋白质、RNA、DNA的合成;能调节胆固醇代谢、降血脂、降血糖;有促性腺激素样作用;尚有抗炎、抗过敏、抗利尿、抗肿瘤、抗溃疡、抗辐射、保肝、抗氧化等作用;
三七的主要功效为散瘀止血,消肿定痛。具有抗血栓形成、抗脑缺血、抗心肌损伤、抗心律失常、抗炎、改善学习记忆、抗疲劳等作用;
北沙参用于肺热燥咳,劳嗽痰血,胃阴不足,热病津伤,咽干口渴;有镇咳祛痰平喘、抗胃溃疡、调节免疫等多种药理作用;
当归具有补血活血,调经止痛,润肠通便的功效;有保护心脏、抗心律失常、抗动脉粥样硬化心肌梗死,抑制平滑肌,抗血小板聚集,抗炎,增强机体免疫功能,脑缺血损伤的保护,抗肿瘤,使细胞增殖,保护肝脏和肾脏等作用;
白芷具有解表散寒、祛风止痛、通鼻窍、燥湿止带、消肿排脓、祛风止痒的功效;主要用于风寒感冒、头痛、牙痛、痹桶等多种疼痛,鼻渊,带下证,疮痈肿毒,皮肤风湿瘙痒等;
黄芩具有清热燥湿、泻火解毒、止血、安胎的功效;主要用于湿温、暑湿、胸闷呕恶、湿热痞满;本品性味苦寒,功能清热燥湿,善清肺胃及大肠至湿热,尤长于清中上焦湿热;
羌活具有散表寒、祛风湿、利关节、止痛的功效,主要用于外感风寒、头痛无汗、油印寒湿痹、风水浮肿、疮疡肿毒;
金荞麦具有清热解毒、祛痰排脓、散瘀止痛、健脾除湿的功效;主要含黄烷醇衍生物、表儿茶素等黄酮类成分、双聚原矢车菊素等有机酸类成分、阿魏酸、绿原酸等;本品有祛痰、解热、抗炎、抗肿瘤、免疫调节、降血糖、降血脂、抗血小板聚集等作用;
鱼腥草具有清热解毒、消痈、排脓、利尿通淋的功能;本品有抗菌、抗病毒、解热、抗炎、镇咳、抗肿瘤、抗辐射、抗过敏、提高机体免疫力等多种药理作用;
清半夏具有燥湿化痰的功效;清半夏有镇吐、镇咳、祛痰、抗菌、抗癌、抗早孕作用;本品经制以后镇吐作用加强;对实验性室性心律失常和室性期前收缩有明显的对抗作用;有显著的抑制胃液分泌作用,对胃溃疡有显著的预防和治疗作用。
桔梗具有宣肺利咽,祛痰排脓的功效;现代药理研究,具有祛痰,止咳,抗菌,抗炎,增强免疫,抑制胃液分泌,抗溃疡,降低血压,降低胆固醇,镇静,镇痛,抗过敏等作用;现代应用此药,可以用来治疗肺炎、急性咽炎、声带小结、小儿病毒性与消化不良性肠炎、黄褐斑等多种疾病;
全瓜蒌具有清热涤痰、宽胸散结、润燥滑肠的功效;有镇咳、祛痰、扩血管、抗溃疡、抗心肌缺血、抗癌等多种药理作用;
玄参具有清热凉血、泻火解毒、滋阴的功效;主要用于温邪入营、内陷心包、温毒发斑;本品咸寒入血分而能清热凉血;
杭芍,即白芍,具有护肝、保护心血管、调经养血等功效;
生白术具有补脾益气、燥湿利水、固表止汗的功效;有利尿、抗菌、抗衰老、抗肿瘤等作用,对神经系统、子宫平滑肌、肠胃运动也有一定作用,还具有调节免疫功能;
百部具有止咳润肺、除虫灭虱、治新久咳嗽、肺痨、百日咳、蛲虫病、体虱、癣疥;百部含有生物碱、糖、蛋白、脂类等多种成分,有湿润肺气、化痰止咳、抗菌杀虫的作用;百部中的生物碱能对抗组织胺引起的气管痉挛,并能降低呼吸中枢兴奋性,抑制咳嗽反射而镇咳;
地龙具有清热熄风、通络、平喘、利尿、降压的作用,地龙入肝经,走血分,既清血分之热,又可解毒,同时还能熄风止惊,可以治疗高热、热极生风所致的神昏谵语、痉挛抽搐、小儿惊风、癫痫、癫狂等;
露蜂房具有攻毒杀虫、祛风止痛的功效,可治疗乳腺炎、皮肤肿胀之感染性疾病,淋巴结核、淋巴结炎,顽固性皮癣;对肺结节具有抗菌消炎的功效与作用;蜂房有益气养肾,养肺润肠的作用,可以解毒护肝,促进组织再生,可以改善睡眠的质量,对儿童的生长发育有一定的帮助;治疗肾虚可以起到辅助效果;
前胡用于痰热喘满、咯痰黄稠、风热咳嗽痰多;本品有祛痰、平喘、镇咳、解热、抗炎、镇痛、抗心肌缺血、抗心律失常、抑制血小板聚集、改善微循环等多种药理作用;
白前具有降气,消痰,止咳的功效;主要用于肺气壅实、咳嗽痰多、胸满喘急;具有镇咳和祛痰、平喘、抗炎、镇痛作用,对消化系统有作用,有抗血栓形成作用;
炙甘草具有止咳化痰、益气、缓急止疼、调和药效的功效,主要用于治疗腹痛、四肢痉挛、疼痛;
生姜具有解表散寒、温和止呕、温肺止咳、解毒的功效,主要用于风寒感冒、脾胃寒症、胃寒呕吐、肺寒咳嗽、解鱼蟹毒;
罗汉果具有清热润肺、利咽开音、滑肠通便的功能;能清解温热疫毒之邪,有良好的清热解毒作用,可疏散再表之风热,适宜于温热病卫气营血各个阶段,为治疗热毒痈肿疔疮的要药,善清肺热,化痰饮,且可利咽止痛,常用治痰嗽、气喘、痢疾等;
竹茹具有清热化痰、除烦、止呕的功效,主要用于痰热咳嗽、胆火挟痰、惊悸不宁、心烦失眠、中风痰迷、舌强不语、胃热呕吐、妊娠恶阻、胎动不安等;
土茯苓具有解毒、除湿、通利关节的功效,主要用于杨梅毒疮、肢体拘挛等;本品甘淡,解毒利湿,通利关节,又兼解汞毒。
由以上分析可以看出,经上述药物的有效组合,君臣相左,互相扶持,对治疗病毒性肺炎且感染危重型高危人疗效明显,成人儿童均可服用,值得临床推广。本发明遵循中医处方用药原则,组方合理、用药安全、疗效好、使用方便。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚,下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。
在本发明实施例的描述中,需要说明的是,若出现术语“中心”、“上”、“下”、“左”、“右”、“竖直”、“水平”、“内”、“外”等指示的方位或位置关系所示的方位或位置关系,或者是该发明产品使用时惯常摆放的方位或位置关系,仅是为了便于描述本发明和简化描述,而不是指示或暗示所指的装置或元件必须具有特定的方位、以特定的方位构造和操作,因此不能理解为对本发明的限制。此外,术语“第一”、“第二”、“第三”等仅用于区分描述,而不能理解为指示或暗示相对重要性。
此外,若出现术语“水平”、“竖直”、“悬垂”等术语并不表示要求部件绝对水平或悬垂,而是可以稍微倾斜。如“水平”仅仅是指其方向相对“竖直”而言更加水平,并不是表示该结构一定要完全水平,而是可以稍微倾斜。
在本发明实施例的描述中,“多个”代表至少2个。
在本发明实施例的描述中,还需要说明的是,除非另有明确的规定和限定,若出现术语“设置”、“安装”、“相连”、“连接”应做广义理解,例如,可以是固定连接,也可以是可拆卸连接,或一体地连接;可以是机械连接,也可以是电连接;可以是直接相连,也可以通过中间媒介间接相连,可以是两个元件内部的连通。对于本领域的普通技术人员而言,可以根据具体情况理解上述术语在本发明中的具体含义。
实施例一:
一种治疗肺炎病毒的中药组合物,所述中药组合物是由以下重量份的中药原料制成:鹿角片13克、山羊角10克、炙黄芪10克、人参5克、三七5克、北沙参10克、当归5克、白芷8克、黄芩4克、羌活5克、金荞麦5克、鱼腥草10克、清半夏10克、桔梗5克、全瓜蒌8克、玄参10克、杭芍10克、生白术10克、百部5克、地龙8克、露蜂房2.5克、前胡5克、白前5克、炙甘草3克、生姜10克、罗汉果5克、竹茹5克、土茯苓4克。
本实施例在具体实施时,首先将称量好的鹿角片、山羊角先煎,人参、三七另外炖,最后将所有组合物水煎一起成中药组合物,一日两次服用。
实施例二:
一种治疗肺炎病毒的中药组合物,所述中药组合物是由以下重量份的中药原料制成:鹿角片36克、山羊角30克、炙黄芪30克、人参15克、三七15克、北沙参30克、当归15克、白芷25克、黄芩11克、羌活15克、金荞麦15克、鱼腥草30克、清半夏30克、桔梗15克、全瓜蒌24克、玄参30克、杭芍30克、生白术30克、百部15克、地龙24克、露蜂房7.5克、前胡15克、白前15克、炙甘草9克、生姜30克、罗汉果15克、竹茹15克、土茯苓11克。
本实施例在具体实施时,首先将称量好的鹿角片、山羊角先煎,人参、三七另外炖,最后将所有组合物水煎一起成中药组合物,一日两次服用。
典型案例:
赵某某,男,96岁,有冠心病史,2022年12月11日,感染肺炎后还在咳嗽的二女儿去看望后,患者就出现了乏力、胸闷、气喘,吃了备用的正气九味羌活汤1包后症状消失。25日,大女儿给他做羮吃,多放了盐,患者吃羮后口渴,就拼命喝水,到了半夜上厕所时摔倒在地。26日,吃了备用的戴芬1粒、本配方一次计量后好转。27日,午饭后喝了一碗水后,突然张嘴说不出,上氧气后还是喝不下药,来电求救,我建议用小勺子一小口一小口的喂,喂下一次计量的本配方后稍缓。28日,喝了重症方一次计量后精神好转,口也不渴了,度过了临床危重期。除夕夜在小儿子的守护下平安过大年。12月28日,临床恢复期,给患者服用本配方后,患者能自己到外面走动。之后每天按量服用,到1月5号完全恢复了,至今平安。
以上对本发明及其实施方式进行了描述,这种描述没有限制性,所示的也只是本发明的实施方式之一,实际的结构并不局限于此。总而言之如果本领域的普通技术人员受其启示,在不脱离本发明创造宗旨的情况下,不经创造性的设计出与该技术方案相似的结构方式及实施例,均应属于本发明的保护范围。
Claims (4)
1.一种治疗肺炎病毒的中药组合物,其特征在于,所述中药组合物是由以下重量份的中药原料制成:鹿角片13-75克、山羊角10-60克、炙黄芪10-60克、人参5-30克、三七5-30克、北沙参10-60克、当归5-30克、白芷8-50克、黄芩4-24克、羌活5-30克、金荞麦5-30克、鱼腥草10-60克、清半夏10-60克、桔梗5-30克、全瓜蒌8-48克、玄参10-60克、杭芍10-60克、生白术10-60克、百部5-30克、地龙8-48克、露蜂房2.5-15克、前胡5-30克、白前5-30克、炙甘草3-18克、生姜10-60克、罗汉果5-30克、竹茹5-30克、土茯苓4-24克。
2.根据权利要求1所述的一种治疗肺炎病毒的中药组合物,其特征在于,所述中药组合物是由以下重量份的中药原料制成:鹿角片13-36克、山羊角10-30克、炙黄芪10-30克、人参5-15克、三七5-15克、北沙参10-30克、当归5-15克、白芷8-25克、黄芩4-11克、羌活5-15克、金荞麦5-15克、鱼腥草10-30克、清半夏10-30克、桔梗5-15克、全瓜蒌8-24克、玄参10-30克、杭芍10-30克、生白术10-30克、百部5-15克、地龙8-24克、露蜂房2.5-7.5克、前胡5-15克、白前5-15克、炙甘草3-9克、生姜10-30克、罗汉果5-15克、竹茹5-15克、土茯苓4-11克。
3.根据权利要求1所述的一种治疗肺炎病毒的中药组合物,其特征在于,所述中药组合物是由以下重量份的中药原料制成:鹿角片13克、山羊角10克、炙黄芪10克、人参5克、三七5克、北沙参10克、当归5克、白芷8克、黄芩4克、羌活5克、金荞麦5克、鱼腥草10克、清半夏10克、桔梗5克、全瓜蒌8克、玄参10克、杭芍10克、生白术10克、百部5克、地龙8克、露蜂房2.5克、前胡5克、白前5克、炙甘草3克、生姜10克、罗汉果5克、竹茹5克、土茯苓4克。
4.根据权利要求1所述的一种治疗肺炎病毒的中药组合物,其特征在于,所述中药组合物是由以下重量份的中药原料制成:鹿角片36克、山羊角30克、炙黄芪30克、人参15克、三七15克、北沙参30克、当归15克、白芷25克、黄芩11克、羌活15克、金荞麦15克、鱼腥草30克、清半夏30克、桔梗15克、全瓜蒌24克、玄参30克、杭芍30克、生白术30克、百部15克、地龙24克、露蜂房7.5克、前胡15克、白前15克、炙甘草9克、生姜30克、罗汉果15克、竹茹15克、土茯苓11克。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA2023/08486A ZA202308486B (en) | 2023-09-04 | 2023-09-04 | Traditional chinese medicine composition for treating pneumovirus |
ZA2023/08486 | 2023-09-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117205294A true CN117205294A (zh) | 2023-12-12 |
Family
ID=89051201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311342604.XA Pending CN117205294A (zh) | 2023-09-04 | 2023-10-17 | 一种治疗肺炎病毒的中药组合物 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN117205294A (zh) |
ZA (1) | ZA202308486B (zh) |
-
2023
- 2023-09-04 ZA ZA2023/08486A patent/ZA202308486B/en unknown
- 2023-10-17 CN CN202311342604.XA patent/CN117205294A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
ZA202308486B (en) | 2024-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104840722A (zh) | 一种功能性养生珍品的组合物及其制备方法、应用方法 | |
KR20040095000A (ko) | 사상의학에 의한 체질별 주류 조성물 및 그 제조방법 | |
CN110151683A (zh) | 一种润肺止咳秋梨膏及其制备方法 | |
CN102772778A (zh) | 一种治疗暑湿感冒的中药组合物 | |
CN103977368B (zh) | 一种用于治疗风湿寒热所致痹病的中药组合物及其制备方法 | |
CN104815192A (zh) | 一种治疗高血压的药物组合物及其应用 | |
CN106177786A (zh) | 一种治疗艾滋病的中药组合物及其制备方法 | |
CN104873826A (zh) | 一种可清肺祛湿的茶饮及其制备方法 | |
CN101721558B (zh) | 小儿止咳口服液 | |
CN111097021A (zh) | 治疗新冠肺炎轻症、疑似者和急性呼吸道感染中药组合物 | |
CN109289033A (zh) | 一种治疗寒湿胃病的中药组合物及制备方法 | |
CN117205294A (zh) | 一种治疗肺炎病毒的中药组合物 | |
CN100353985C (zh) | 止咳喘与润肺的药物及其制备方法 | |
CN106474376A (zh) | 一种儿科治疗反复上呼吸道感染的中药组合物 | |
CN111888479A (zh) | 一种改善不良口感的中药伴侣及其制作方法 | |
CN104784476A (zh) | 一种治疗心律不齐的中药胶囊及制备方法 | |
CN1254259C (zh) | 治疗心脑血管疾病的中药制剂及其制备方法 | |
CN105250417A (zh) | 一种治疗腹泻型肠易激综合征的药物组合物及其应用 | |
CN104096202B (zh) | 一种治疗秋季腹泻的药物及其制备方法 | |
CN111759901B (zh) | 一种治疗儿童功能性腹痛的中药组合物及其制备方法 | |
CN101837062B (zh) | 一种降脂口含片 | |
CN105455004A (zh) | 一种胃下垂患者食用的面条 | |
CN104435900A (zh) | 治疗风湿性关节炎的药物及制法 | |
CN104524386A (zh) | 一种用于结核病防治的中药组合物及其制备方法 | |
CN104288637A (zh) | 一种具有清肺止咳作用的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |